GI
PFE icon

GAMMA Investing’s Pfizer PFE Stock Holding History

GAMMA Investing’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Buy
85,702
+1,868
+2% +$48.9K 0.08% 206
2026
Q1 		$2.35M Buy
83,834
+12,548
+18% +$334K 0.11% 161
2025
Q4 		$1.78M Sell
71,286
-63
-0.1% -$1.59K 0.09% 184
2025
Q3 		$1.82M Buy
71,349
+9,436
+15% +$233K 0.1% 170
2025
Q2 		$1.5M Sell
61,913
-1,218
-2% -$28.4K 0.09% 187
2025
Q1 		$1.6M Buy
63,131
+25,785
+69% +$675K 0.12% 155
2024
Q4 		$991K Sell
37,346
-2,558
-6% -$69.4K 0.08% 209
2024
Q3 		$1.15M Buy
39,904
+13,097
+49% +$382K 0.11% 168
2024
Q2 		$750K Buy
26,807
+13,039
+95% +$359K 0.1% 178
2024
Q1 		$382K Buy
13,768
+1,149
+9% +$31.9K 0.08% 243
2023
Q4 		$342K Buy
+12,619
New +$381K 0.09% 190

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GAMMA Investing's PFE Position: Q2 2026 in Review

GAMMA Investing increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $48.9K and bringing the position to 85,702 shares worth $2.06M. The position accounts for 0.08% of the portfolio, ranked #206.

GAMMA Investing first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.35M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • GAMMA Investing held 85,702 shares of Pfizer worth $2.06M as of Q2 2026.
  • GAMMA Investing bought 1,868 Pfizer shares in Q2 2026, an estimated $48.9K.
  • Pfizer made up 0.08% of GAMMA Investing's portfolio in Q2 2026, its #206 holding.
  • GAMMA Investing first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Pfizer position peaked at $2.35M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.